Clinical trial

FFAR Agonist on Incretins, Insulin, Lipids and Inflammation

NCT03062592

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-02-01

PhaseNA

Study timeline

Study start (actual)2016-02-01Date precision: month

Registry last updated2018-12-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetes Mellitusunresolved

Obesityunresolved

Interventions

Pine nut oilDIETARY_SUPPLEMENT

Sponsors & collaborators

Odense University Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03062592 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.